CEO Corner

Welcome from the CEO:

On behalf of the CDEX Team, I would like to thank you for your interest and support of our company. CDEX is a technology development company, we develop, manufacture and distribute products for the healthcare and security markets utilizing our proprietary patented technology.

Our Healthcare Market division product line includes the ValiMed Medication Validation System, which provides accurate, immediate, real-time validation of drugs, the detection of foreign materials or substances, and aides in training and quality assurance in the healthcare environment.

The Valimed System addresses three problem areas in the healthcare market:
· Human error in the compounding of medications,
· Harmful counterfeit medications
· Diversion of hospital narcotics.

Our Security Market division includes CDEX ID2 Product Line, which provides real time detection of specified illegal drugs. The ID2 Product Line consists of two instruments:

· ID2 Meth Scanner is a hand-held device for detecting all forms of methamphetamines and has been calibrated to meet California remediation standards.
· Pocket ID2 Scanner provides a more portable and easily concealed device for convenience and security purposes for use in law enforcement, prisons, DEA, homeland security, border patrol and other applicable environments. Our Pocket ID2 is currently being developed to detect other narcotics such as cocaine, heroin, crack and other illicit drug signatures.

This forum will provide a brief review of key milestones we have achieved as a company, as well as provide a look forward toward future significant events.

Our corporate website reflects our ongoing efforts to provide up-to-date information regarding our products and services to our customers while being a primary source for investors and shareholders to learn more about CDEX’s progress in the market.

Please feel free to contact me or a member of our team should you have any questions. I look forward to providing future updates as we execute our business strategy and build our company.

God Bless,

Jeff Brumfield, CEO of CDEX Inc.

CDEX AT-A-GLANCE

A brief overview of our Company. COMING SOON.

GET THE LATEST UPDATES

Sign up for CDEX Inc – Newsletter






* = required field


SEC FILINGS

CDEX’s Filing of Forms, Statements and Reports Required by the U.S. Securities and Exchange Commission can be viewed here.

View our most recent annual report  Here and Here.

PRESS RELEASES

Scan Headlines for Investor Related News Topics GO TO LINK
Contact Us at investorrelations@cdex-inc.com
Disclaimer: Please See SEC Filings for Full Disclosures